Brevan Howard Capital Management’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
27,869
-13,478
-33% -$163K ﹤0.01% 1651
2026
Q1
$467K Sell
41,347
-1,612
-4% -$19.3K ﹤0.01% 1341
2025
Q4
$546K Buy
42,959
+10,810
+34% +$144K 0.01% 1064
2025
Q3
$420K Buy
32,149
+20,365
+173% +$280K ﹤0.01% 1384
2025
Q2
$161K Buy
+11,784
New +$166K ﹤0.01% 1747
2025
Q1
– Sell
-31,586
Closed -$483K – 1372
2024
Q4
$483K Buy
+31,586
New +$506K ﹤0.01% 632

Other funds holding OCSL

Brevan Howard Capital Management's OCSL Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Oaktree Specialty Lending (OCSL) stake by 33% in Q2 2026, selling an estimated $163K and leaving 27,869 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Brevan Howard Capital Management first reported a position in OCSL in Q4 2024 and has held it in 6 quarters since. The position peaked at $546K in Q4 2025. 165 funds tracked by Wall St. Rank hold OCSL as of Q2 2026.

  • Brevan Howard Capital Management held 27,869 shares of Oaktree Specialty Lending worth $333K as of Q2 2026.
  • Brevan Howard Capital Management sold 13,478 Oaktree Specialty Lending shares in Q2 2026, an estimated $163K.
  • Oaktree Specialty Lending made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1651 holding.
  • Brevan Howard Capital Management first reported a position in Oaktree Specialty Lending in Q4 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Oaktree Specialty Lending position peaked at $546K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.